Post

Global Unique Device Identification Database (GUDID) Data Submission and Management Requirements

This guidance provides detailed information for device labelers on submitting data to the Global Unique Device Identification Database (GUDID). It covers GUDID account management, device identifier (DI) record submission requirements, package information handling, and data retrieval options. The guidance applies to medical devices that require UDI labeling under 21 CFR 801.20.

  1. Establish GUDID account and determine submission method (Web Interface or HL7 SPL)
  2. Ensure proper DUNS numbers are obtained and verified for organization and labelers
  3. Identify and assign appropriate personnel roles:
    • Regulatory Contact
    • GUDID Coordinator(s)
    • Labeler Data Entry users
  4. Develop SOPs for:
    • Data quality management
    • DI record submission process
    • Record maintenance and updates
    • Data governance if using multiple submission methods
  5. Obtain GMDN membership and identify appropriate GMDN terms for devices
  6. Implement system to track and manage:
    • DI record states (Draft, Unpublished, Published)
    • Grace period editing windows
    • Package configuration information
    • Commercial distribution dates
  7. Establish process for maintaining records according to 21 CFR Part 11 requirements
  8. Create system for monitoring and updating GMDN terms throughout device lifecycle
  9. Set up procedure for handling device discontinuation and associated GUDID updates
  10. If using third-party submitters, establish oversight mechanisms to ensure data accuracy and compliance

Key Considerations

Software

  • Stand-alone software version number may be represented as Lot or Batch number production identifier
  • Two submission options available:
    • Web Interface for manual entry (low volume)
    • HL7 SPL XML file submission via FDA ESG (high volume)

Cybersecurity

  • Secure submission required through FDA Electronic Submissions Gateway (ESG) for HL7 SPL submissions
  • Digital certificates needed for authentication of submissions through ESG

Labelling

  • UDI must appear on device label and packages unless excepted
  • Device identification data in GUDID should match information on device label
  • For attributes appearing in medical device labeling, values submitted to GUDID should be consistent with labeling

Other considerations

  • HL7: Standards for interoperability and healthcare data exchange
  • 21 CFR Part 11: Electronic Records; Electronic Signatures
  • 21 CFR 830: Unique Device Identification
  • 21 CFR 801: Labeling

Original guidance

  • Global Unique Device Identification Database (GUDID) Data Submission and Management Requirements
  • HTML / PDF
  • Issue date: 2024-12-17
  • Last changed date: 2024-12-17
  • Status: FINAL
  • Official FDA topics: UDI, GUDID, Medical Devices, Labeling, Biologics
  • ReguVirta summary file ID: 9f88c74af2bcae97fcaf1f788e116baf
This post is licensed under CC BY 4.0 by the author.